Innovative Cancer Drug Development
Utilizing AI and In Silico Methodology
Oncova Biosciences is an emerging, virtual Biotech cancer drug development company utilizing AI and in silico methodology to produce cancer drugs targeting novel previously resistant mutated genes that intiate and maintain cancer.
Targeted Cancer Therapies
Our focus on developing targeted cancer therapies aims to provide advanced treatment options for various types of cancer, offering hope and improved quality of life to cancer patients in need.
Advanced Biomarker Detection
We are dedicated to advancing biomarker detection tools to enable early and accurate diagnosis of cancer, leading to timely interventions and better patient outcomes.
Precision Oncology
Advancing precision oncology allows us to tailor cancer treatments to individual patients based on their genetic mutations and specific cancer characteristics, ensuring more effective and precise care.
Novel Drug Targets
Our research in identifying novel drug targets in cancer cells has the potential to revolutionize cancer treatment by offering new avenues for developing effective anti-cancer drugs, paving the way for improved outcomes in cancer care.